Skip to main content
Pideka Group Inc. logo

Pideka Group Inc. — Investor Relations & Filings

Ticker · PDKA ISIN · CA72004D1069 CSE Manufacturing
Open in API
Filings indexed 81 across all filing types
Latest filing 2020-03-21 Regulatory Filings
Country CA Canada
Listing CSE PDKA

About Pideka Group Inc.

https://www.grupopideka.com/

Pideka Group Inc. is a multi-national operator specializing in the cultivation, production, and distribution of pharmaceutical-grade cannabis and its derivatives. The company utilizes medical-grade indoor cultivation facilities and laboratories to produce raw cannabis flower and specialized derivatives intended for scientific and pharmaceutical applications. Pideka's product offerings include pharmaceutical grade cannabinoids, decarboxylated flower, finished CBD products, and finished ingredient cannabis oil. The company focuses on providing high-quality medicinal cannabis products designed to meet or exceed international standards, serving markets through integrated operations that include cultivation, production, and distribution.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of the annual filings, including the AIF, annual financial statements, and annual MD&A for the financial year ended November 30, 2019. The document is a certification letter and does not contain actual financial data or the full annual report itself. It explicitly states it is a certification and includes disclaimers about controls and procedures. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than the actual Annual Report (10-K) or other financial reports. The document length is short (3135 characters), consistent with a certification letter rather than a full report. Therefore, the correct classification is Regulatory Filings (RNS).
2020-03-21 English
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled 'Management’s Discussion & Analysis' (MD&A) for the year ended November 30, 2019, prepared as of March 19, 2020. It discusses the financial condition, results of operations, liquidity, and capital resources of Canadian Imperial Venture Corp. for the fiscal year ended November 30, 2019. It references the annual audited consolidated financial statements but does not contain the full financial statements itself. The document includes detailed management commentary on financial results, business overview, and outlook, which is characteristic of an MD&A report. It is not an Annual Report (10-K) because it does not contain the full financial statements, nor is it a Regulatory Filing or Report Publication Announcement since it contains substantive financial analysis and discussion. Therefore, the document fits the category of Management Reports (MDA).
2020-03-21 English
Audited annual financial statements – English.pdf
Annual Report Classification · 100% confidence The document is titled 'INDEPENDENT AUDITOR’S REPORT' and contains an auditor's opinion on the consolidated financial statements of Canadian Imperial Venture Corp. for the years ended November 30, 2019 and 2018. It includes detailed audit procedures, auditor responsibilities, and an opinion on the financial statements prepared under IFRS. The document also contains the consolidated financial statements themselves, including statements of financial position, loss and comprehensive loss, cash flows, changes in shareholders' equity, and notes to the financial statements. The presence of the auditor's report combined with the full consolidated financial statements for a fiscal year indicates this is a full Annual Report filing. The document length (15,000 characters) and content confirm it is not a brief announcement or certification but a comprehensive financial report. Therefore, the appropriate classification is Annual Report (10-K).
2020-03-21 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 13-501F1 related to reporting issuers and participation fees, including a management certification by the CFO. It contains detailed financial data related to market values, securities outstanding, and fees payable. The presence of a management certification and detailed financial figures indicates this is a regulatory filing related to compliance and fee reporting rather than a full financial report like an Annual or Interim Report. The document is not an announcement or a brief summary but a formal certification and fee calculation submission to a securities commission. Therefore, it fits best under Regulatory Filings (RNS).
2020-03-21 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a detailed corporate update from Canadian Imperial Venture Corp. regarding its subsidiary Ikänik Farms. It includes extensive narrative about business operations, strategic developments, certifications, product branding, and future plans. The text is a news release providing a comprehensive update on corporate activities rather than a formal financial report or regulatory filing. There are no financial statements, earnings highlights, or regulatory certifications present. The document is not a transcript, proxy, or voting result announcement. It is a corporate update news release, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement and corporate update that does not fit other specific categories.
2020-03-13 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release announcing that Ikänik Farms has obtained GMP-PHARMA certification for its cultivation and manufacturing facility in Colombia. It discusses the significance of this certification, the company's operations, and the pending business combination transaction. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The document is primarily an announcement of a corporate development and certification achievement, not a financial report or regulatory filing. It also includes forward-looking statements and disclaimers typical of press releases. Therefore, this document fits best into the category of a general Regulatory Filing (RNS) as it is a regulatory announcement/news release that does not fit into more specific categories like Annual Report, Earnings Release, or Capital Update.
2020-01-31 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.